๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Management of small cell carcinoma of the lung. Therapy, staging, and biochemical markers

โœ Scribed by Martin D. Abeloff; David S. Ettinger; Stephen B. Baylin; Tapan Hazra


Publisher
John Wiley and Sons
Year
1976
Tongue
English
Weight
661 KB
Volume
38
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Results of combined-modality therapy for
โœ Steven E. Schild; Philip J. Stella; Burke J. Brooks; Sumithra Mandrekar; James A ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 106 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND A Phase III trial was conducted by the North Central Cancer Treatment Group to determine whether chemotherapy (etoposide and cisplatin) plus either twiceโ€daily radiotherapy (BIDRT) or onceโ€daily radiotherapy (QDRT) resulted in a better outcome for patients with limitedโ€st

Combination chemotherapy and radiation t
โœ Robert T. Eagan; L. Herbert Maurer; R. Jackson Forcier; Marchant Tulloh ๐Ÿ“‚ Article ๐Ÿ“… 1973 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 786 KB

Twenty-eight patients with small cell carcinoma of the lung were studied for their response to combination chemotherapy and radiation therapy, frequency of bone marrow metastases, and clinically evident hormonal syndromes. Seventeen of 19 evaluable patients who received cyclic monthly courses of hig